Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 9: anonymization and ethics considerations for capturing and sharing patient reported outcomes.

Arbuckle L, Moher E, Bartlett SJ, Ahmed S, El Emam K.

J Clin Epidemiol. 2017 Sep;89:168-172. doi: 10.1016/j.jclinepi.2017.04.016. Epub 2017 Apr 20.

PMID:
28433677
2.

Stop Predatory Publishers Now.

Moher D, Moher E.

Ann Intern Med. 2016 Dec 6;165(11):826-827. doi: 10.7326/L16-0415. No abstract available.

PMID:
27919084
3.

Stop Predatory Publishers Now: Act Collaboratively.

Moher D, Moher E.

Ann Intern Med. 2016 May 3;164(9):616-7. doi: 10.7326/M15-3015. Epub 2016 Feb 2. No abstract available.

PMID:
26830517
4.

The Ethical Merits of Nudges in the Clinical Setting.

Moher E, El Emam K.

Am J Bioeth. 2015;15(10):54-5. doi: 10.1080/15265161.2015.1074309. No abstract available.

PMID:
26479107
5.

Secure surveillance of antimicrobial resistant organism colonization or infection in Ontario long term care homes.

El Emam K, Arbuckle L, Essex A, Samet S, Eze B, Middleton G, Buckeridge D, Jonker E, Moher E, Earle C.

PLoS One. 2014 Apr 8;9(4):e93285. doi: 10.1371/journal.pone.0093285. eCollection 2014.

6.

Privacy and anonymity challenges when collecting data for public health purposes.

El Emam K, Moher E.

J Law Med Ethics. 2013 Mar;41 Suppl 1:37-41. doi: 10.1111/jlme.12036.

PMID:
23590738
7.

A review of evidence on consent bias in research.

El Emam K, Jonker E, Moher E, Arbuckle L.

Am J Bioeth. 2013;13(4):42-4. doi: 10.1080/15265161.2013.767958. No abstract available.

PMID:
23514396
8.

Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.

Deshauer D, Moher D, Fergusson D, Moher E, Sampson M, Grimshaw J.

CMAJ. 2008 May 6;178(10):1293-301. doi: 10.1503/cmaj.071068. Review.

9.

Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.

Liang J, Moore RE, Moher ED, Munroe JE, Al-awar RS, Hay DA, Varie DL, Zhang TY, Aikins JA, Martinelli MJ, Shih C, Ray JE, Gibson LL, Vasudevan V, Polin L, White K, Kushner J, Simpson C, Pugh S, Corbett TH.

Invest New Drugs. 2005 Jun;23(3):213-24.

PMID:
15868377
10.

(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.

Collado I, Pedregal C, Bueno AB, Marcos A, González R, Blanco-Urgoiti J, Pérez-Castells J, Schoepp DD, Wright RA, Johnson BG, Kingston AE, Moher ED, Hoard DW, Griffey KI, Tizzano JP.

J Med Chem. 2004 Jan 15;47(2):456-66.

PMID:
14711315
11.

Synthesis of cryptophycin 52 using the Shi epoxidation.

Hoard DW, Moher ED, Martinelli MJ, Norman BH.

Org Lett. 2002 May 16;4(10):1813-5.

PMID:
12000306
12.

Catalytic regioselective sulfonylation of alpha-chelatable alcohols: scope and mechanistic insight.

Martinelli MJ, Vaidyanathan R, Pawlak JM, Nayyar NK, Dhokte UP, Doecke CW, Zollars LM, Moher ED, Khau VV, Kosmrlj B.

J Am Chem Soc. 2002 Apr 10;124(14):3578-85.

PMID:
11929246
13.

Synthesis of Unit A of Cryptophycin via a [2,3]-Wittig Rearrangement.

Liang J, Hoard DW, Khau VV, Martinelli MJ, Moher ED, Moore RE, Tius MA.

J Org Chem. 1999 Mar 5;64(5):1459-1463.

PMID:
11674204
14.
15.

Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).

Varie DL, Shih C, Hay DA, Andis SL, Corbett TH, Gossett LS, Janisse SK, Martinelli MJ, Moher ED, Schultz RM, Toth JE.

Bioorg Med Chem Lett. 1999 Feb 8;9(3):369-74.

PMID:
10091686
16.

Anticancer activity of glaucarubinone analogues.

Valeriote FA, Corbett TH, Grieco PA, Moher ED, Collins JL, Fleck TJ.

Oncol Res. 1998;10(4):201-8.

PMID:
9778691

Supplemental Content

Support Center